Differences in endothelial function amongst Sitagliptin and Liraglutide Users: A randomized, open-label, parallel-group and active controlled trial

Trial Profile

Differences in endothelial function amongst Sitagliptin and Liraglutide Users: A randomized, open-label, parallel-group and active controlled trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Sep 2015

At a glance

  • Drugs Liraglutide (Primary) ; Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Sep 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Feb 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health,NCT01785043).
    • 05 Feb 2013 Planned end date changed from 15 May 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top